Navigation Links
New Clues for Treating Ulcerative Colitis
Date:6/16/2010

Scientists spot chemical tied to remission of the debilitating bowel disease

WEDNESDAY, June 16 (HealthDay News) -- A chemical that may trigger remission in people with ulcerative colitis has been identified by Canadian researchers.

The team at McMaster University in Hamilton, Ontario, found that ulcerative colitis patients in long-term remission have elevated levels of prostaglandin D2. Previous research in rats found that this chemical plays an important role in healing and remission of the disease.

"The levels of prostaglandin D2 were only elevated in those patients in long-term remission, and that suggests it is a key factor in preventing new episodes of ulcerative colitis," John Wallace, director of the Farncombe Family Digestive Health Research Institute at McMaster, said in a university news release.

Wallace, a professor of medicine at the Michael G. DeGroote School of Medicine, said the finding may help lead to a new treatment for ulcerative colitis and possibly to Crohn's disease as well.

Ulcerative colitis involves a chronic inflammation of the inner lining of the rectum and colon that can lead to abdominal pain and cramping, diarrhea, bleeding and weight loss. The condition affects millions of people worldwide. Treatment options are still limited, however, and most people are never cured.

The study was published June 14 in the journal Proceedings of the National Academy of Sciences.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about ulcerative colitis.



-- Robert Preidt



SOURCE: McMaster University, June 14, 2010, news release.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Gene Mutations Offer Clues to Autoimmune Disorders
2. Cysts hold clues to pancreatic cancer
3. Tracking PSA Test Results Over Time Gives Clues to Cancer
4. New Clues to Treating Immune System Disorders
5. New Clues to Treating an Aggressive Breast Cancer
6. Pigs Yield Clues to Cystic Fibrosis-Related Lung Disease
7. New Clues Shed Light on Sperm Function, Male Fertility
8. Ovarian cancer study offers vital clues for new therapies
9. Change in breast density over time provides clues about breast cancer risk
10. Lab that probes genetic clues to disease is poised for major expansion
11. More Clues Emerge on How HIV Infects Women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Clues for Treating Ulcerative Colitis
(Date:4/30/2016)... ... April 30, 2016 , ... Create an abstract ... can distort and manipulate three-dimensional shapes with ease all within Apple Motion ... lines, polygons, polygon texture animation, opacity texture animation, overall shape texture displacement, twist, ...
(Date:4/30/2016)... ... April 30, 2016 , ... Dr. ... CEO of EMED, today signed a multifaceted agreement which will allow for the ... Caribbean University Department of Natural and Applied Sciences, Allied Health and Nursing will ...
(Date:4/29/2016)... , ... April 30, 2016 , ... ... of patented products, announces the Pick Up Springboard, an automotive invention that improves ... Truck Manufacturing industry is worth $162 billion," says Scott Cooper, CEO and Creative ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Accreditation Council for Graduate Medical Education (ACGME) that it has received accreditation for ... first accreditation of three residency programs that Memorial is currently pursuing, including Pediatrics ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... of our nation’s productivity, stability, even security. Most importantly, employees are the single ... Then why are American workers so unhappy? , Just under half of American ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 Global  urinalysis ... billion by 2022, according to a new report ... (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... efficiency and accuracy delivered by the new generation ... novel urinalysis instruments and consumables. For instance, the ...
(Date:4/27/2016)... -- At the Sachs CEO forum in ... 2 clinical study of its lead drug candidate, STR001, ... (CI) surgery. This large, placebo-controlled, double-blind, phase 2 study ... and France . STR001 is ... of surgery. "Despite advances in cochlear implant technology, a ...
(Date:4/26/2016)... , April 26, 2016 Hill-Rom Holdings, Inc. ... a management presentation at the Deutsche Bank 41 st ... 2:50 p.m. EDT. You are invited to listen ... http://ir.hill-rom.com/events.cfm or access it directly at http://edge.media-server.com/m/p/mr4uxgas . ... hour after conclusion of the live event and accessible at ...
Breaking Medicine Technology: